Skip to main content
Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
    • SGC Gender Equality Plan
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
    • SGC Unicamp
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Target 2035
      • Contribute your Proteins to Target 2035
      • AIRCHECK
      • MAINFRAME
      • CACHE
      • Conscience
      • Agora Open Science Trust
      • EUbOPEN
      • Open Chemistry Networks
      • Women’s and Children’s Health Initiative
      • READDI AViDD
      • TREAT AD
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us
  • Home
  • About
    • About SGC
    • Member Funders
    • Governance
    • Open Science
    • Impact
  • SGC Sites & People
    • Global
    • SGC Toronto
    • SGC UNC
    • SGC Karolinska
    • SGC Frankfurt
    • SGC Neuro
    • SGC UCL
  • Science and Resources
    • Proteins
      • Structure Gallery
      • Protein Production Resources
        • Expression Vectors
        • Constructs
    • Chemistry
      • Chemical Probes
        • SGC Chemical Probes
        • Donated Chemical Probes
        • Chemical Handles
      • Chemogenomic Sets
        • EUbOPEN Chemogenomic Sets
        • KCGS
    • Open Data
    • Target Enabling Packages
    • Patient Tissue Platform
    • Open Lab Notebooks
    • Publications
    • Bioinformatics Resources
      • ChemBioPort
      • UbiHub
      • ChromoHub
  • Initiatives
    • Overview
      • Open Chemistry Networks
      • Target 2035
      • CACHE
      • Women’s and Children’s Health Initiative
      • Viral Medicines Initiative
      • READDI AViDD
      • Agora Open Science Trust
      • TREAT AD
      • EUbOPEN
      • YCharOS
  • News & Outreach
    • News from SGC
    • Press Releases
    • Blogs
  • Get Involved
    • Participate
    • Donate
    • Careers
    • Contact Us

Genetic Variability of the SARS-CoV-2 Pocketome.

  • Read more about Genetic Variability of the SARS-CoV-2 Pocketome.

MYC protein interactors in gene transcription and cancer.

  • Read more about MYC protein interactors in gene transcription and cancer.

Conformational plasticity of the ULK3 kinase domain.

  • Read more about Conformational plasticity of the ULK3 kinase domain.

Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.

  • Read more about Probing the SAM Binding Site of SARS-CoV-2 Nsp14 In Vitro Using SAM Competitive Inhibitors Guides Developing Selective Bisubstrate Inhibitors.

NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.

  • Read more about NEK5 activity regulates the mesenchymal and migratory phenotype in breast cancer cells.

Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors.

  • Read more about Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors.

Integrated analysis of Shank1 PDZ interactions with C-terminal and internal binding motifs.

  • Read more about Integrated analysis of Shank1 PDZ interactions with C-terminal and internal binding motifs.

Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.

  • Read more about Rapid and accurate agglutination-based testing for SARS-CoV-2 antibodies.

Opinion: Independent third-party entities as a model for validation of commercial antibodies.

  • Read more about Opinion: Independent third-party entities as a model for validation of commercial antibodies.

Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.

  • Read more about Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 168
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • Page 173
  • Page 174
  • Page 175
  • Page 176
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

A global public-private partnership that supports the discovery of new medicines through open-access research.

  • Careers
  • Contact Us

Structural Genomics Consortium. Registered charity 04714553 (England and Wales). Registered company limited by guarantee 1097737 (England and Wales). Except where otherwise noted, all content on this site is licensed under a Creative Commons Attribution 4.0 International license (CC BY 4.0)

Be the first to know with our SGC Bulletin!

Want to know what we are up to?
Leave your e-mail address below and you will receive a monthly source of SGC news from across our six research sites.

SIGN UP FOR OUR NEWSLETTER

Footer

  • Privacy Policy
  • Legal Information
  • Accessbility
  • Contact Us
  • Login

Toronto website development by Rebel Trail